• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估 FRESH 评分在预测欧洲患者队列动脉瘤性蛛网膜下腔出血后结局和生活质量中的作用。

Evaluation of FRESH scores in predicting outcome and quality of life after aneurysmal subarachnoid haemorrhage in a European patient cohort.

机构信息

Department of Neurosurgery, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.

Department of Anesthesiology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.

出版信息

Acta Neurochir (Wien). 2024 Jan 23;166(1):29. doi: 10.1007/s00701-024-05909-2.

DOI:10.1007/s00701-024-05909-2
PMID:38261024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10806023/
Abstract

BACKGROUND

Despite aneurysmal subarachnoid haemorrhage (aSAH) patients often experiencing physical and mental disabilities impacting their quality of life (QoL), routine assessment of long-term QoL data and predictive tools are limited. This study evaluates the newly developed "functional recovery expected after subarachnoid haemorrhage" (FRESH) scores with long-term outcomes and QoL in European aSAH patients.

METHODS

FRESH, FRESH-cog, and FRESH-quol scores were retrospectively obtained from aSAH patients. Patients were contacted, and the modified Rankin Scale (mRS), extended short form-36 (SF-36), and telephone interview for cognitive status (TICS) were collected and performed. The prognostic and empirical outcomes were compared.

RESULTS

Out of 374 patients, 171 patients (54.1%) completed the SF-36, and 154 patients completed the TICS. The SF-36 analysis showed that 32.7% had below-average physical component summary (PCS) scores, and 39.8% had below-average mental component summary (MCS) scores. There was no significant correlation between the FRESH score and PCS (p = 0.09736), MCS (p = 0.1796), TICS (p = 0.7484), or mRS 10-82 months (average 46 months) post bleeding (p = 0.024), respectively. There was also no significant correlation found for "FRESH-cog vs. TICS" (p = 0.0311), "FRESH-quol vs. PCS" (p = 0.0204), "FRESH-quol vs. MCS" (p = 0.1361) and "FRESH-quol vs. TICS" (p = 0.1608).

CONCLUSIONS

This study found no correlation between FRESH scores and validated QoL tools in a European population of aSAH patients. The study highlights the complexity of reliable long-term QoL prognostication in aSAH patients and emphasises the need for further prospective research to also focus on QoL as an important outcome parameter.

摘要

背景

尽管动脉瘤性蛛网膜下腔出血(aSAH)患者常经历影响其生活质量(QoL)的身体和精神残疾,但长期 QoL 数据和预测工具的常规评估仍有限。本研究评估了新开发的“蛛网膜下腔出血后预期功能恢复”(FRESH)评分与欧洲 aSAH 患者的长期结局和 QoL 的相关性。

方法

回顾性获取 aSAH 患者的 FRESH、FRESH-cog 和 FRESH-quol 评分。联系患者并收集和执行改良 Rankin 量表(mRS)、扩展短表单-36(SF-36)和电话认知状态访谈(TICS)。比较了预测和经验性结果。

结果

在 374 名患者中,171 名患者(54.1%)完成了 SF-36,154 名患者完成了 TICS。SF-36 分析显示,32.7%的患者生理成分综合评分(PCS)较低,39.8%的患者心理成分综合评分(MCS)较低。FRESH 评分与 PCS(p=0.09736)、MCS(p=0.1796)、TICS(p=0.7484)或出血后 10-82 个月(平均 46 个月)的 mRS 之间均无显著相关性(p=0.024)。“FRESH-cog 与 TICS”(p=0.0311)、“FRESH-quol 与 PCS”(p=0.0204)、“FRESH-quol 与 MCS”(p=0.1361)和“FRESH-quol 与 TICS”(p=0.1608)之间也未发现显著相关性。

结论

本研究在欧洲 aSAH 患者人群中未发现 FRESH 评分与经验证的 QoL 工具之间存在相关性。该研究强调了可靠的长期 QoL 预测在 aSAH 患者中的复杂性,并强调需要进一步进行前瞻性研究,也将 QoL 作为一个重要的结局参数进行关注。

相似文献

1
Evaluation of FRESH scores in predicting outcome and quality of life after aneurysmal subarachnoid haemorrhage in a European patient cohort.评估 FRESH 评分在预测欧洲患者队列动脉瘤性蛛网膜下腔出血后结局和生活质量中的作用。
Acta Neurochir (Wien). 2024 Jan 23;166(1):29. doi: 10.1007/s00701-024-05909-2.
2
Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗增殖性糖尿病视网膜病变的比较:一项系统评价和个体参与者数据荟萃分析
Health Technol Assess. 2025 Apr 2:1-75. doi: 10.3310/MJYP6578.
3
Non-pharmacological interventions for sleep promotion in hospitalized children.促进住院儿童睡眠的非药物干预措施。
Cochrane Database Syst Rev. 2022 Jun 15;6(6):CD012908. doi: 10.1002/14651858.CD012908.pub2.
4
Prognostic factors for return to work in breast cancer survivors.乳腺癌幸存者恢复工作的预后因素。
Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2.
5
Aural toilet (ear cleaning) for chronic suppurative otitis media.慢性化脓性中耳炎的耳道清理(耳部清洁)
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
6
Pelvic floor muscle training with feedback or biofeedback for urinary incontinence in women.针对女性尿失禁的盆底肌训练及反馈或生物反馈训练
Cochrane Database Syst Rev. 2025 Mar 11;3(3):CD009252. doi: 10.1002/14651858.CD009252.pub2.
7
Mucolytics for children with chronic suppurative lung disease.用于患有慢性化脓性肺病儿童的黏液溶解剂。
Cochrane Database Syst Rev. 2025 Mar 28;3(3):CD015313. doi: 10.1002/14651858.CD015313.pub2.
8
Long-term mechanical failure in well aligned adult spinal deformity patients.成年脊柱畸形患者脊柱排列良好时的长期机械性失效
Spine J. 2025 Feb;25(2):337-346. doi: 10.1016/j.spinee.2024.09.019. Epub 2024 Sep 26.
9
Dynamic changes of platelets before and after surgery predict the prognosis of patients with aneurysmal subarachnoid hemorrhage.手术前后血小板的动态变化可预测动脉瘤性蛛网膜下腔出血患者的预后。
Heliyon. 2024 Sep 10;10(18):e37706. doi: 10.1016/j.heliyon.2024.e37706. eCollection 2024 Sep 30.
10
Anti-VEGF drugs compared with laser photocoagulation for the treatment of diabetic retinopathy: a systematic review and meta-analysis.抗血管内皮生长因子药物与激光光凝术治疗糖尿病性视网膜病变的比较:一项系统评价和荟萃分析。
Health Technol Assess. 2024 Dec 11:1-71. doi: 10.3310/PCGV5709.

引用本文的文献

1
Multi-class subarachnoid hemorrhage severity prediction: addressing challenges in predicting rare outcomes.多类别蛛网膜下腔出血严重程度预测:应对罕见结局预测中的挑战。
Neurosurg Rev. 2025 Jul 10;48(1):554. doi: 10.1007/s10143-025-03678-9.
2
Health-related quality of life after spontaneous subarachnoid hemorrhage - a prospective cohort study.自发性蛛网膜下腔出血后的健康相关生活质量——一项前瞻性队列研究。
Qual Life Res. 2025 Mar 27. doi: 10.1007/s11136-025-03955-6.
3
Validation of prognostic stroke scores-comments on "Evaluation of FRESH scores in predicting outcome and quality of life after aneurysmal subarachnoid haemorrhage in a European patient cohort": Author's response.

本文引用的文献

1
Revisiting the WFNS Score: Native Computed Tomography Imaging Improves Identification of Patients With "False Poor Grade" Aneurysmal Subarachnoid Hemorrhage.重新审视 WFNS 评分:原生计算机断层成像有助于识别“假性差级”的动脉瘤性蛛网膜下腔出血患者。
Neurosurgery. 2024 Mar 1;94(3):515-523. doi: 10.1227/neu.0000000000002715. Epub 2023 Oct 12.
2
Evaluation of MTT Heterogeneity of Perfusion CT Imaging in the Early Brain Injury Phase: An Insight into aSAH Pathopysiology.早期脑损伤阶段灌注CT成像MTT异质性评估:对蛛网膜下腔出血病理生理学的洞察
Brain Sci. 2023 May 19;13(5):824. doi: 10.3390/brainsci13050824.
3
Blood Pressure Affects the Early CT Perfusion Imaging in Patients with aSAH Reflecting Early Disturbed Autoregulation.
预后性卒中评分的验证——对“欧洲患者队列中FRESH评分在预测动脉瘤性蛛网膜下腔出血后的结局和生活质量中的评估”的评论:作者回应
Acta Neurochir (Wien). 2024 Apr 2;166(1):161. doi: 10.1007/s00701-024-06048-4.
4
Validation of prognostic stroke scores - comments on "Evaluation of FRESH scores in predicting outcome and quality of life after aneurysmal subarachnoid haemorrhage in a European patient cohort".预后性卒中评分的验证——对“欧洲患者队列中FRESH评分对动脉瘤性蛛网膜下腔出血后结局和生活质量的预测评估”的评论
Acta Neurochir (Wien). 2024 Mar 28;166(1):156. doi: 10.1007/s00701-024-06046-6.
血压影响 aSAH 患者早期 CT 灌注成像,反映早期自主调节功能障碍。
Neurocrit Care. 2023 Aug;39(1):125-134. doi: 10.1007/s12028-023-01683-8. Epub 2023 Feb 17.
4
Long-Term Cognitive Outcome following Aneurysmal Subarachnoid Haemorrhage.颅内动脉瘤性蛛网膜下腔出血的长期认知结局。
J Stroke Cerebrovasc Dis. 2022 Jan;31(1):106184. doi: 10.1016/j.jstrokecerebrovasdis.2021.106184. Epub 2021 Nov 10.
5
MTT Heterogeneity in Perfusion CT Imaging as a Predictor of Outcome after Aneurysmal SAH.CT 灌注成像中的 MTT 异质性作为动脉瘤性蛛网膜下腔出血后结局的预测因子。
AJNR Am J Neuroradiol. 2021 Aug;42(8):1387-1395. doi: 10.3174/ajnr.A7169. Epub 2021 Jun 3.
6
Cognitive deficits among patients surviving aneurysmal subarachnoid hemorrhage. A contemporary systematic review.颅内动脉瘤性蛛网膜下腔出血患者的认知缺陷。当代系统评价。
Br J Neurosurg. 2021 Aug;35(4):384-401. doi: 10.1080/02688697.2020.1859462. Epub 2020 Dec 21.
7
Survival, Dependency, and Health-Related Quality of Life in Patients With Ruptured Intracranial Aneurysm: 10-Year Follow-up of the United Kingdom Cohort of the International Subarachnoid Aneurysm Trial.颅内破裂动脉瘤患者的生存、依赖和健康相关生活质量:国际蛛网膜下腔动脉瘤试验英国队列的 10 年随访。
Neurosurgery. 2021 Jan 13;88(2):252-260. doi: 10.1093/neuros/nyaa454.
8
Early Prognostication of 1-Year Outcome After Subarachnoid Hemorrhage: The FRESH Score Validation.蛛网膜下腔出血 1 年后预后的早期预测:FRESH 评分验证。
J Stroke Cerebrovasc Dis. 2019 Oct;28(10):104280. doi: 10.1016/j.jstrokecerebrovasdis.2019.06.038. Epub 2019 Jul 18.
9
Prediction of Outcome After Aneurysmal Subarachnoid Hemorrhage.动脉瘤性蛛网膜下腔出血预后的预测。
Stroke. 2019 Apr;50(4):837-844. doi: 10.1161/STROKEAHA.118.023902.
10
Development and validation of outcome prediction models for aneurysmal subarachnoid haemorrhage: the SAHIT multinational cohort study.颅内动脉瘤性蛛网膜下腔出血结局预测模型的建立和验证:SAHIT 多中心队列研究。
BMJ. 2018 Jan 18;360:j5745. doi: 10.1136/bmj.j5745.